Geneos Wealth Management’s 10x Genomics TXG Stock Holding History

Geneos Wealth Management’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$249K	Sell	6,500 -1,000	-13%	-$26.2K	0.01%	922
2026 Q1	$159K	Buy	7,500 +5,149	+219%	+$103K	﹤0.01%	1033
2025 Q4	$38.3K	Buy	+2,351	New	+$35.5K	﹤0.01%	1496
2025 Q3	–	Sell	-133	Closed	-$1.54K	–	3148
2025 Q2	$1.54K	Sell	133 -17	-11%	-$155	﹤0.01%	2878
2025 Q1	$1.31K	Buy	150 +101	+206%	+$1.27K	﹤0.01%	2873
2024 Q4	$704	Buy	+49	New	+$773	﹤0.01%	2839

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geneos Wealth Management's TXG Position: Q2 2026 in Review

Geneos Wealth Management reduced its 10x Genomics (TXG) stake by 13% in Q2 2026, selling an estimated $26.2K and leaving 6,500 shares worth $249K. The position accounts for 0.01% of the portfolio, ranked #922.

Geneos Wealth Management first reported a position in TXG in Q4 2024 and has held it in 6 quarters since. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Geneos Wealth Management held 6,500 shares of 10x Genomics worth $249K as of Q2 2026.
Geneos Wealth Management sold 1,000 10x Genomics shares in Q2 2026, an estimated $26.2K.
10x Genomics made up 0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #922 holding.
Geneos Wealth Management first reported a position in 10x Genomics in Q4 2024 and has held it in 6 quarters since.
393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.